Susquehanna International Group, LLP Xtant Medical Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 35,440 shares of XTNT stock, worth $23,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,440
Previous 107,123
66.92%
Holding current value
$23,744
Previous $50,000
48.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XTNT
# of Institutions
30Shares Held
79.9MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT68.4MShares$45.8 Million2.21% of portfolio
-
Awm Investment Company, Inc. New York, NY6.6MShares$4.42 Million0.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$1.51 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny651KShares$435,9750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA554KShares$370,9280.0% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $72.5M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...